Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 321.70K | 56.70K | 193.70K | 689.10K | 277.60K |
| Total Receivables | 36.40K | 122.60K | 95.90K | 85.30K | 62.90K |
| Inventory | 87.90K | 100.80K | 35.20K | 111.20K | 61.60K |
| Prepaid Expenses | 21.30K | 23.70K | 102.10K | 32.30K | 69.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 467.30K | 303.80K | 426.90K | 917.90K | 471.30K |
|
|
|||||
| Total Current Assets | 467.30K | 303.80K | 426.90K | 917.90K | 471.30K |
| Net Property, Plant & Equipment | 1.86M | 1.85M | 1.79M | 1.75M | 1.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.20K | 10.30K | 10.00K | 10.20K | 10.20K |
| Total Assets | 2.33M | 2.16M | 2.22M | 2.68M | 2.14M |
|
|
|||||
| Total Accounts Payable | 983.20K | 913.70K | 588.50K | 449.60K | 343.60K |
| Total Accrued Expenses | 706.50K | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.00K | 29.30K | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 319.10K | 734.80K | 709.00K | 1.14M | 1.10M |
| Total Other Current Liabilities | 319.10K | 734.80K | 709.00K | 1.14M | 1.10M |
| Total Current Liabilities | 2.04M | 1.68M | 1.30M | 1.59M | 1.44M |
|
|
|||||
| Total Current Liabilities | 2.04M | 1.68M | 1.30M | 1.59M | 1.44M |
| Long-Term Debt | -- | -- | 28.60K | 29.10K | 29.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 10.20K | 10.20K |
| Total Liabilities | 2.04M | 1.68M | 1.33M | 1.63M | 1.48M |
|
|
|||||
| Common Stock & APIC | 11.89M | 11.47M | 11.17M | 10.87M | 9.52M |
| Retained Earnings | -11.60M | -11.00M | -10.28M | -9.83M | -8.87M |
| Treasury Stock & Other | 11.90K | 9.50K | 15.00K | 8.70K | 12.10K |
| Total Common Equity | 296.10K | 484.50K | 896.50K | 1.05M | 664.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 296.10K | 484.50K | 896.50K | 1.05M | 664.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 296.10K | 484.50K | 896.50K | 1.05M | 664.20K |
|
|
|||||